Exosomal miR-17 Drives Thyroid Cancer Lung Metastasis via NF-κB Activation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung metastasis is a major cause of death in thyroid cancer.
• The molecular mechanisms driving thyroid cancer lung metastasis are not fully understood.
• The "seed and soil" hypothesis suggests that the metastatic site (soil) influences cancer cell colonization.

Purpose of the Study:

• To investigate the role of exosomal microRNA-17-5p (miR-17-5p) in promoting thyroid cancer lung metastasis.
• To explore the molecular mechanisms by which miR-17-5p facilitates lung metastasis.
• To assess the potential of miR-17-5p as a therapeutic target.

Main Methods:

• Serum exosomes from thyroid cancer patients with lung metastasis and controls were analyzed for miR-17 levels.
• miR-17 was introduced into lung fibroblasts (MRC-5) and co-cultured with thyroid cancer cells (Cal62).
• Cell proliferation, migration, cytokine levels (IL-6, IL-8), and signaling pathways (NF-κB, NKRF) were assessed. In vivo studies were conducted.

Main Results:

• miR-17-5p was significantly elevated in serum exosomes of metastatic thyroid cancer patients.
• miR-17-5p suppressed NKRF, activated NF-κB signaling, and increased IL-6/IL-8 secretion in lung fibroblasts.
• This remodeling of the lung microenvironment enhanced thyroid cancer cell proliferation and migration, confirmed in vivo.

Conclusions:

• Exosomal miR-17-5p transforms the pulmonary microenvironment into a pro-inflammatory niche.
• This facilitates thyroid cancer cell colonization and metastasis to the lungs.
• miR-17-5p represents a potential therapeutic target for managing thyroid cancer lung metastasis.